Greek hematologist Dr. Ilias Theodoropoulos (left) speaks during a workshop on Micell's Stem M-Cell at the IV Congreso Semdor Valencia conference in Valentia, Spain, on Oct. 25. (Miracell)

South Korean stem cell research company Miracell showcased its stem cell extraction system, Smart M-Cell, during the IV Congreso Semdor Valencia conference in Spain last month.

Hosted by the Spanish Pain Society, the annual conference brought together pain management experts from around the world to explore effective solutions for preventing and treating pain. This year’s event, held Oct. 24-26, invited doctors from Spain, the UK, the US, the Netherlands, Greece and Italy.

During the conference, Miracell showcased Smart M-Cell and its specialized kits, drawing interest from attending medical professionals, according to the company.

Greek hematologist Dr. Ilias Theodoropoulos and Spanish regenerative medicine specialist Dr. Luis Miguel Torres led a workshop during the conference to examine Smart M-Cell’s clinical applications in pain management, specifically comparing the effectiveness of intravenous and localized stem cell treatments.

“Over the past year, I have administered more than 400 stem cell treatments and observed notable improvements in patient outcomes,” Theodoropoulos said, adding that he plans to publish a paper summarizing these clinical results.

Miracell also said it plans to work with international Smart M-Cell users to collect clinical data and share findings at future conferences, contributing to ongoing discussions around the technology’s role in pain management.

“Several hospitals, including university medical centers, have expressed interest in adopting Smart M-Cell following the conference,” said an official from Sieben, Miracell's Spanish distributor, adding that distribution is anticipated to begin in early 2025.